Raquel Guerrero-Alba1, Eduardo Emmanuel Valdez-Morales1, Nestor Nivardo Jiménez-Vargas1, Romke Bron2, Daniel Poole2,3, David Reed1, Joel Castro4,5, Melissa Campaniello5, Patrick A Hughes5, Stuart M Brierley4,5, Nigel Bunnett2,6,7, Alan E Lomax1, Stephen Vanner1. 1. Gastrointestinal Diseases Research Unit, Queen's University, Kingston, ON, Canada. 2. Monash Institute of Pharmaceutical Sciences and Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, VIC, Australia. 3. Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, VIC, Australia. 4. Visceral Pain Research Group, Human Physiology, Centre for Neuroscience, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia. 5. Centre for Nutrition and Gastrointestinal Diseases, Discipline of Medicine, University of Adelaide, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia. 6. Department of Pharmacology and Therapeutics, The University of Melbourne, Parkville, VIC, Australia. 7. Departments of Surgery and Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Abstract
BACKGROUND AND PURPOSE: To better understand opioid signalling in visceral nociceptors, we examined the expression and selective activation of μ and δ opioid receptors by dorsal root ganglia (DRG) neurons innervating the mouse colon. EXPERIMENTAL APPROACH: DRG neurons projecting to the colon were identified by retrograde tracing. δ receptor-GFP reporter mice, in situ hybridization, single-cell RT-PCR and μ receptor-specific antibodies were used to characterize expression of μ and δ receptors. Voltage-gated Ca2+ currents and neuronal excitability were recorded in small diameter nociceptive neurons (capacitance <30 pF) by patch clamp and ex vivo single-unit afferent recordings were obtained from the colon. KEY RESULTS: In situ hybridization of oprm1 expression in Fast Blue-labelled DRG neurons was observed in 61% of neurons. μ and δ receptors were expressed by 36-46% of colon DRG neurons, and co-expressed by ~25% of neurons. μ and δ receptor agonists inhibited Ca2+ currents in DRG, effects blocked by opioid antagonists. One or both agonists inhibited action potential firing by colonic afferent endings. Incubation of neurons with supernatants from inflamed colon segments inhibited Ca2+ currents and neuronal excitability. Antagonists of μ, but not δ receptors, inhibited the effects of these supernatant on Ca2+ currents, whereas both antagonists inhibited their actions on neuronal excitability. CONCLUSIONS AND IMPLICATIONS: A significant number of small diameter colonic nociceptors co-express μ and δ receptors and are inhibited by agonists and endogenous opioids in inflamed tissues. Thus, opioids that act at μ or δ receptors, or their heterodimers may be effective in treating visceral pain.
BACKGROUND AND PURPOSE: To better understand opioid signalling in visceral nociceptors, we examined the expression and selective activation of μ and δ opioid receptors by dorsal root ganglia (DRG) neurons innervating the mouse colon. EXPERIMENTAL APPROACH: DRG neurons projecting to the colon were identified by retrograde tracing. δ receptor-GFP reporter mice, in situ hybridization, single-cell RT-PCR and μ receptor-specific antibodies were used to characterize expression of μ and δ receptors. Voltage-gated Ca2+ currents and neuronal excitability were recorded in small diameter nociceptive neurons (capacitance <30 pF) by patch clamp and ex vivo single-unit afferent recordings were obtained from the colon. KEY RESULTS: In situ hybridization of oprm1 expression in Fast Blue-labelled DRG neurons was observed in 61% of neurons. μ and δ receptors were expressed by 36-46% of colon DRG neurons, and co-expressed by ~25% of neurons. μ and δ receptor agonists inhibited Ca2+ currents in DRG, effects blocked by opioid antagonists. One or both agonists inhibited action potential firing by colonic afferent endings. Incubation of neurons with supernatants from inflamed colon segments inhibited Ca2+ currents and neuronal excitability. Antagonists of μ, but not δ receptors, inhibited the effects of these supernatant on Ca2+ currents, whereas both antagonists inhibited their actions on neuronal excitability. CONCLUSIONS AND IMPLICATIONS: A significant number of small diameter colonic nociceptors co-express μ and δ receptors and are inhibited by agonists and endogenous opioids in inflamed tissues. Thus, opioids that act at μ or δ receptors, or their heterodimers may be effective in treating visceral pain.
Authors: Monica Verma-Gandhu; Premysl Bercik; Yasuaki Motomura; Elena F Verdu; Waliul I Khan; Patricia A Blennerhassett; Lu Wang; Rami T El-Sharkawy; Stephen M Collins Journal: Gastroenterology Date: 2006-05 Impact factor: 22.682
Authors: Patrick A Hughes; Joel Castro; Andrea M Harrington; Nicole Isaacs; Melissa Moretta; Gareth A Hicks; David M Urso; Stuart M Brierley Journal: Gut Date: 2013-11-27 Impact factor: 23.059
Authors: D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard Journal: Gut Date: 2005-11-18 Impact factor: 23.059
Authors: Stephen Ph Alexander; Arthur Christopoulos; Anthony P Davenport; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2017-12 Impact factor: 8.739
Authors: Raquel Guerrero-Alba; Eduardo Emmanuel Valdez-Morales; Nestor Nivardo Jiménez-Vargas; Romke Bron; Daniel Poole; David Reed; Joel Castro; Melissa Campaniello; Patrick A Hughes; Stuart M Brierley; Nigel Bunnett; Alan E Lomax; Stephen Vanner Journal: Br J Pharmacol Date: 2018-05-22 Impact factor: 8.739
Authors: Douglas A Drossman; Carolyn B Morris; Hollie Edwards; Christina Ed Wrennall; Stephan R Weinland; Ademola O Aderoju; Renuka R Kulkarni-Kelapure; Yuming J Hu; Christine Dalton; Megan H Bouma; Joseph Zimmerman; Ceciel Rooker; Jane Leserman; Shrikant I Bangdiwala Journal: Am J Gastroenterol Date: 2012-06-19 Impact factor: 10.864
Authors: Raquel Guerrero-Alba; Eduardo Emmanuel Valdez-Morales; Nestor Nivardo Jiménez-Vargas; Romke Bron; Daniel Poole; David Reed; Joel Castro; Melissa Campaniello; Patrick A Hughes; Stuart M Brierley; Nigel Bunnett; Alan E Lomax; Stephen Vanner Journal: Br J Pharmacol Date: 2018-05-22 Impact factor: 8.739
Authors: Nestor Nivardo Jiménez-Vargas; Yang Yu; Dane D Jensen; Diana Daeun Bok; Matthew Wisdom; Rocco Latorre; Cintya Lopez; Josue O Jaramillo-Polanco; Claudius Degro; Mabel Guzman-Rodriguez; Quentin Tsang; Zachary Snow; Brian L Schmidt; David E Reed; Alan Edward Lomax; Kara Gross Margolis; Christoph Stein; Nigel W Bunnett; Stephen J Vanner Journal: Gut Date: 2021-03-30 Impact factor: 23.059
Authors: Yang Yu; Quentin K Tsang; Josue Jaramillo-Polanco; Alan E Lomax; Stephen J Vanner; David E Reed Journal: J Neurosci Date: 2022-07-05 Impact factor: 6.709
Authors: Josue Jaramillo-Polanco; Cintya Lopez-Lopez; Yang Yu; Emma Neary; Alan Hegron; Meritxell Canals; Nigel W Bunnett; David E Reed; Alan E Lomax; Stephen J Vanner Journal: J Neurosci Date: 2022-03-07 Impact factor: 6.709
Authors: Nestor N Jimenez-Vargas; Jing Gong; Matthew J Wisdom; Dane D Jensen; Rocco Latorre; Alan Hegron; Shavonne Teng; Jesse J DiCello; Pradeep Rajasekhar; Nicholas A Veldhuis; Simona E Carbone; Yang Yu; Cintya Lopez-Lopez; Josue Jaramillo-Polanco; Meritxell Canals; David E Reed; Alan E Lomax; Brian L Schmidt; Kam W Leong; Stephen J Vanner; Michelle L Halls; Nigel W Bunnett; Daniel P Poole Journal: Proc Natl Acad Sci U S A Date: 2020-06-16 Impact factor: 11.205